Predicting cancer recurrence after surgery with immune markers
Part of Cancer clinical trials.
This study looks at your immune system and your tumor to help build a model that predicts if cancer might come back after surgery. The goal is to improve how we plan follow-up care and possibly guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a type of cancer that can be removed with surgery (like liver, lung, stomach, or colorectal cancer).
- You are not pregnant or breastfeeding, and you don't plan to be within the next 2 years.
- You are willing to sign a consent form to join the study.
- You are willing to provide a sample of your tumor for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a lab test on your tumor can better predict the chance that non-metastatic colon cancer will come back after surgery. Researchers will compare relapse risk using the Immunoscore® test to help guide follow-up and treatment decisions.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This study looks at how certain immune cells relate to Crohn's disease coming back after bowel surgery. The goal is to better understand why some patients have a recurrence, which could help improve future treatments.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
This study tests a new way to predict if non-small cell lung cancer will return after surgery. You will give blood samples to look for cancer cells, and the team will build a model to help plan better follow-up care.
This study follows people who have had breast cancer come back in the same area after their first surgery. It aims to learn more about local recurrence to improve future treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.